Using this technique, the research team has shown evidence for lung, liver and spleen specific targeting in mice, and efficient gene editing of PTEN and PCSK9, therapeutic targets for cancer and hypercholesterolaemia, respectively [104]. The gene discussed is PCSK9; the disease is cancer.